Expertise in
40
conditions

Dr. Andrew J. Hart

Oncology
Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, 
Louisville, KY 
Accepting New Patients
Expertise in
40
conditions
Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, 
Louisville, KY 

Overview

Andrew Hart is an Oncologist practicing medicine in Louisville, Kentucky.

Dr. Hart is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, Lung Cancer, and Endoscopy.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 4 clinical trials. Dr. Hart is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in KY

Hospital Affiliations

Baptist Health Lagrange
Baptist Health Hardin
Baptist Health Louisville

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, Louisville, KY 40207
Other Locations
Baptist Health Medical Group-Hematology & Oncology
2400 Eastpoint Pkwy Ste 310, Louisville, KY 40223

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
Enrollment Status: Active_not_recruiting
Publish Date: May 22, 2026
Intervention Type: Procedure, Biological, Drug, Other, Radiation
Study Drugs: Carboplatin, Cisplatin, Doxorubicin, Durvalumab, Gemcitabine, Methotrexate, Vinblastine, Fluorouracil, Mitomycin C
Study Phase: Phase 2
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
View 3 Less Clinical Trials

2 Total Publications

A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma.
A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 08, 2013
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Uofl Health-Brown Cancer Center

529 S Jackson St, 
Louisville, KY 
 (4.9 miles away)
502-562-4673
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Chesney is an Oncologist practicing medicine in Louisville, Kentucky. Dr. Chesney is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Melanoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Chesney is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Norton Cancer Institute Brownsboro

4955 Norton Healthcare Blvd, 
Louisville, KY 
 (5.5 miles away)
502-394-6350
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Renato La Rocca is an Oncologist practicing medicine in Louisville, Kentucky. Dr. La Rocca is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, and Atypical Teratoid Rhabdoid Tumor (ATRT). Dr. La Rocca is currently accepting new patients.

Expertise in
59
conditions
Dr. Michael D. Kommor
Hematology | Oncology
Expertise in
59
conditions
Dr. Michael D. Kommor
Hematology | Oncology
Referral may be required

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (0.1 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Kommor is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. Dr. Kommor is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Splenic Neoplasm, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Kommor is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew J. Hart

How do I make an appointment with Dr. Andrew J. Hart?

You can book an appointment with Dr. Andrew J. Hart by calling their office at 502-897-1166. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew J. Hart a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew J. Hart is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew J. Hart specialize in?

While Dr. Andrew J. Hart is a Oncology, they have specific expertise in Colorectal Cancer, Familial Colorectal Cancer, and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Andrew J. Hart participate in research or clinical trials?

Yes. Dr. Andrew J. Hart has published 2 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. Andrew J. Hart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew J. Hart accept my insurance?

Dr. Andrew J. Hart accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 502-897-1166 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hart's expertise for a condition
ConditionClose
    View All 34 Advanced Conditions
    View All 92 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile